DE69428292T2 - Rekombinanter c140-rezeptor, seine agonisten und antagonisten - Google Patents

Rekombinanter c140-rezeptor, seine agonisten und antagonisten

Info

Publication number
DE69428292T2
DE69428292T2 DE69428292T DE69428292T DE69428292T2 DE 69428292 T2 DE69428292 T2 DE 69428292T2 DE 69428292 T DE69428292 T DE 69428292T DE 69428292 T DE69428292 T DE 69428292T DE 69428292 T2 DE69428292 T2 DE 69428292T2
Authority
DE
Germany
Prior art keywords
receptor
permits
antagonists
recombinant
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69428292T
Other languages
English (en)
Other versions
DE69428292D1 (de
Inventor
M Scarborough
Johan Sundelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of DE69428292D1 publication Critical patent/DE69428292D1/de
Application granted granted Critical
Publication of DE69428292T2 publication Critical patent/DE69428292T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69428292T 1993-07-26 1994-07-26 Rekombinanter c140-rezeptor, seine agonisten und antagonisten Expired - Fee Related DE69428292T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/097,938 US5629174A (en) 1993-07-26 1993-07-26 Recombinant C140 receptor
PCT/US1994/008536 WO1995003318A1 (en) 1993-07-26 1994-07-26 Recombinant c140 receptor and its agonists and antagonists

Publications (2)

Publication Number Publication Date
DE69428292D1 DE69428292D1 (de) 2001-10-18
DE69428292T2 true DE69428292T2 (de) 2002-06-27

Family

ID=22265852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428292T Expired - Fee Related DE69428292T2 (de) 1993-07-26 1994-07-26 Rekombinanter c140-rezeptor, seine agonisten und antagonisten

Country Status (12)

Country Link
US (1) US5629174A (de)
EP (1) EP0804452B1 (de)
JP (1) JPH09503906A (de)
KR (1) KR960703939A (de)
CN (1) CN1057118C (de)
AT (1) ATE205502T1 (de)
AU (1) AU701677B2 (de)
CA (1) CA2168232A1 (de)
DE (1) DE69428292T2 (de)
NO (1) NO960341L (de)
NZ (1) NZ271516A (de)
WO (1) WO1995003318A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043212A (en) * 1993-07-26 2000-03-28 Cor Therapeutics, Inc. Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
US20020032314A1 (en) * 1994-10-28 2002-03-14 Chrysalis Biotechnology, Inc. Synthetic peptide neutrophil cell chemotactic agents
US6602978B1 (en) * 1994-10-28 2003-08-05 Chrysalis Biotechnology Synthetic peptide neutrophil cell chemotactic agents
EP0870198A4 (de) * 1995-01-25 2001-04-04 Cor Therapeutics Inc Rekombinanter c140-rezeptor, seine agonsiten und antagonisten, und den rezeptor kodierende nukleinsäuren
US5892014A (en) 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
US6737252B2 (en) 1997-07-25 2004-05-18 Schering Corporation 7 transmembrane receptor family member BLRX
US20030013155A1 (en) * 1998-08-20 2003-01-16 Millennium Pharmaceuticals, Inc. 14400 receptor, a novel G-protein coupled receptor
JP3677421B2 (ja) * 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
KR100436441B1 (ko) * 2001-10-11 2004-06-16 한국화장품주식회사 지속성 립스틱 조성물
FR2883873B1 (fr) * 2005-03-31 2009-07-10 Pharmamens Sarl Inhibiteurs d'age
US7888482B2 (en) 2006-02-10 2011-02-15 Amgen Inc. Antibodies that bind PAR-2
AR070911A1 (es) * 2008-03-19 2010-05-12 Regeneron Pharma Uso de antagonistas del receptor par2 activado con proteasa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019646A (en) * 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5128254A (en) * 1989-11-01 1992-07-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cdna encoding the long isoform of the d2 dopamine receptor
AU701822B2 (en) * 1993-07-26 1999-02-04 Millennium Pharmaceuticals, Inc. Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Also Published As

Publication number Publication date
AU701677B2 (en) 1999-02-04
AU7516794A (en) 1995-02-20
CN1131950A (zh) 1996-09-25
KR960703939A (ko) 1996-08-31
CN1057118C (zh) 2000-10-04
EP0804452A4 (de) 1998-08-12
DE69428292D1 (de) 2001-10-18
ATE205502T1 (de) 2001-09-15
CA2168232A1 (en) 1995-02-02
NO960341D0 (no) 1996-01-26
EP0804452A1 (de) 1997-11-05
NO960341L (no) 1996-03-26
US5629174A (en) 1997-05-13
WO1995003318A1 (en) 1995-02-02
EP0804452B1 (de) 2001-09-12
JPH09503906A (ja) 1997-04-22
NZ271516A (en) 1997-01-29

Similar Documents

Publication Publication Date Title
ATE247165T1 (de) Rekombinanter thrombinrezeptor und verwandte arzneimittel
DE69428292D1 (de) Rekombinanter c140-rezeptor, seine agonisten und antagonisten
WO1998010068A3 (en) Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
CA2309903A1 (en) Nucleic acid sequences encoding capsaicin receptor
ATE203566T1 (de) Protein-g-gekoppelte glutaminsäure-rezeptoren
Barratt The use of anticonvulsants in aggression and violence.
DE3751846D1 (de) Hybrid-Rezeptoren, diese kodierende Nukleinsäure, ihre Herstellung und ihre Verwendung zur Bestimmung von Liganden sowie deren Antagonisten oder Agonisten
BR9808545A (pt) ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
DE69133135D1 (de) Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
DE69011329D1 (de) Pdgf-alpha-rezeptor.
WO1997024436A3 (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
ES2192060T3 (es) Analisis de bioluminiscencia para agonistas o antagonistas de un receptor acoplado al calcio.
Le Brun et al. Identification of endothelin receptors in normal and hyperplasic human prostate tissues
DK0862627T3 (da) Neuropeptid Y-Y5 receptor
Kiener et al. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
FR2663638B2 (fr) Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
Yamayoshi et al. A human IL-1 alpha derivative which lacks prostaglandin E2 inducing activity and inhibits the activity of IL-1 through receptor competition.
WO2004029209A3 (en) Epitope-tagged recombinant growth arrest specific gene 6 protein
EP0892046A3 (de) Melatoninrezeptorexpressionszellen und deren Anwendung
ES2134781T3 (es) Polipeptidos con actividad de receptor dopaminergico humano, acidos nucleicos que codifican dichos polipeptidos y uso de dichos polipeptidos para el cribado de sustancias activas para dichos polipeptidos.
EP0863214A3 (de) Reporter-Gen Konstruktion für die Messung von G Protein gekoppelte Receptor Aktivation
MXPA02010725A (es) Ensayo serologico para neospora caninum.
Jeyakumar et al. Demonstration of complimentarity between monoclonal antibodies (MAbs) to human chorionic gonadotropin (hCG) and polyclonal antibodies to luteinizing hormone/hCG receptor (LH-R) and their use in better understanding hormone-receptor interaction.
Bechtel et al. Inhibition of [3H] clonidine binding to rat brain alpha-adrenoceptors by imidazolidines. Correlation of binding potency and hypotensive activity.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee